The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout

By sjmartinez • March 12, 2024

Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK. The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024 Mar 12. doi: 10.1038/s41584-024-01092-x. Epub ahead of print. PMID: 38472344.

Tags: Publications, Rheumatology, Veterans Administration

Estimating net bone formation relative to resorption using reference bone turnover markers

Shieh A, Karlamangla AS, Gossiel F, Eastell R, Burnett-Bowie SA, Greendale GA. Estimating net bone formation relative to resorption using reference bone turnover markers. J[...]

Development, Implementation, and Evaluation Methods for Dashboards in Health Care: Scoping Review

Helminski D, Sussman JB, Pfeiffer PN, Kokaly AN, Ranusch A, Renji AD, Damschroder LJ, Landis-Lewis Z, Kurlander JE. Development, Implementation, and Evaluation Methods for Dashboards[...]

Genome-Wide DNA Methylation Identifies Potential Disease-Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease

Mahurkar-Joshi S, Thompson M, Villarruel E, Lewis JD, Lin LD, Farid M, Nayeb-Hashemi H, Storage T, Weiss GA, Limketkai BN, Sauk JS, Mayer EA, Chang[...]